Traumatic brain injury in Pakistan linked to poor long-term survival

Traumatic brain injury in Pakistan is associated with a high risk of death and disability long after the initial injury, even in mild to moderate cases.

Protein secreted by immune cells may help drive brain aging

Brain-resident immune cells that have reached an old-age state called “senescence” secrete a protein that causes dysfunction in other brain cells, according to Weill Cornell Medicine researchers, a finding that could shed light on memory loss.

Molecular structures provide roadmap for targeted Parkinson’s disease therapeutics

Researchers have uncovered how a key Parkinson’s protein shifts between inactive and active forms, revealing the structural changes that enable certain mutations to push the protein into an overactive state. 

Breakthrough may change treatment for metastatic prostate cancer

Earlier use of a targeted radionuclide therapy delays metastatic prostate cancer progression when administered as part of a trio of drugs, according to a phase 3 clinical trial.

Scientists identify tumor-secreted protein that promotes lung metastasis in cancer patients

The protein makes blood vessels leakier to allow metastatic tumors to form in the lungs, according to a study led by investigators at Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center.

Coordinating the development of heart muscle and vasculature

A new finding could point toward innovative approaches for treating cardiovascular conditions that lead to heart failure.

A promising solution to a cancer drug resistance problem

A protein that can dial down oxidative stress in cells helps some cancers resist treatment with a widely used class of drugs called BTK inhibitors, according to a study led by investigators at Weill Cornell Medicine.

Cornell Tech appoints new Associate Deans for research and education

Cornell Tech has appointed two longtime faculty leaders to new academic leadership roles.

Around Cornell

Inflammation may drive rare epileptic syndrome

An overactive immune response in the brain may play a role in Dravet syndrome, a rare and severe genetic epilepsy that typically begins in infancy, according to Weill Cornell Medicine researchers.